SCHEMBL2554903

SCHEMBL2554903

COC(=O)c1cc(C(=O)O)cc2c1OCC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.43
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 4/20 0.40
CYP2A6 P11509 1/20 0.37
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
KDM1A O60341 1/20 0.35
XDH P47989 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
MEN1 O00255 2/20 0.34
TP53 P04637 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPT P10636 2/20 0.34
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
DRD2 P14416 1/20 0.34
KDM6B O15054 1/20 0.34
KDM5C P41229 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8364696 0.81 HTR3A (0.50) PARP1KDM4EALDH1A1CYP2A6HTR3A
SCHEMBL12284064 0.81 PARP1 (0.48) PARP1KDM4EALDH1A1CYP2A6MEN1
SCHEMBL31306041 0.81 MAPT (0.49) PARP1KDM4EALDH1A1CYP2A6KMT2A
SCHEMBL4644440 0.81 MAPT (0.49) PARP1KDM4EALDH1A1CYP2A6KMT2A
SCHEMBL2557810 0.80 ATM (0.38) PARP1KDM4EALDH1A1XDHMEN1
SCHEMBL12284065 0.79 ALDH1A1 (0.40) PARP1KDM4EALDH1A1XDHMEN1
SCHEMBL4011401 0.78 PARP1 (0.46) PARP1KDM4EALDH1A1CYP2A6MEN1
SCHEMBL30546095 0.78 PARP1 (0.42) PARP1KDM4EALDH1A1CYP2A6PTGS2
SCHEMBL12283422 0.78 PARP1 (0.42) PARP1KDM4EALDH1A1CYP2A6PTGS2
SCHEMBL4011405 0.77 PARP1 (0.41) PARP1KDM4EALDH1A1CYP2A6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011130383-A1 COMPOUNDS CONTAINING FUSED RINGS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF COMENTIS, INC. (US) 2011-10-20 WO disclosed
WO-2011130383-A1 COMPOUNDS CONTAINING FUSED RINGS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF COMENTIS, INC. (US) 2011-10-20 WO disclosed